Global Pertussis Vaccine Market Growth 2020-2025
According to this study, over the next five years the Pertussis Vaccine market will register a 1.5%% CAGR in terms of revenue, the global market size will reach $ 5142.4 million by 2025, from $ 4844.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pertussis Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Pertussis Vaccine, covering the supply chain analysis, impact assessment to the Pertussis Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Pertussis Vaccine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Whole-cell vaccines
Acellular vaccines
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Children
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi Pasteur
GSK
Wuhan Institute of Biological Products
Walvax Biotechnology
Mitsubishi Tanabe Pharma
Minhai Biotechnology
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pertussis Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pertussis Vaccine market by identifying its various subsegments.
Focuses on the key global Pertussis Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pertussis Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pertussis Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pertussis Vaccine Consumption 2015-2025
2.1.2 Pertussis Vaccine Consumption CAGR by Region
2.2 Pertussis Vaccine Segment by Type
2.2.1 Whole-cell vaccines
2.2.2 Acellular vaccines
2.3 Pertussis Vaccine Consumption by Type
2.3.1 Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pertussis Vaccine Sale Price by Type (2015-2020)
2.4 Pertussis Vaccine Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Pertussis Vaccine Consumption by Application
2.5.1 Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Pertussis Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Pertussis Vaccine Sale Price by Type (2015-2020)
3 Global Pertussis Vaccine by Company
3.1 Global Pertussis Vaccine Sales Market Share by Company
3.1.1 Global Pertussis Vaccine Sales by Company (2018-2020)
3.1.2 Global Pertussis Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Pertussis Vaccine Revenue Market Share by Company
3.2.1 Global Pertussis Vaccine Revenue by Company (2018-2020)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Pertussis Vaccine Sale Price by Company
3.4 Global Pertussis Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pertussis Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pertussis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pertussis Vaccine by Regions
4.1 Pertussis Vaccine by Regions
4.2 Americas Pertussis Vaccine Consumption Growth
4.3 APAC Pertussis Vaccine Consumption Growth
4.4 Europe Pertussis Vaccine Consumption Growth
4.5 Middle East & Africa Pertussis Vaccine Consumption Growth
5 Americas
5.1 Americas Pertussis Vaccine Consumption by Countries
5.1.1 Americas Pertussis Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Pertussis Vaccine Value by Countries (2015-2020)
5.2 Americas Pertussis Vaccine Consumption by Type
5.3 Americas Pertussis Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pertussis Vaccine Consumption by Regions
6.1.1 APAC Pertussis Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Pertussis Vaccine Value by Regions (2015-2020)
6.2 APAC Pertussis Vaccine Consumption by Type
6.3 APAC Pertussis Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pertussis Vaccine by Countries
7.1.1 Europe Pertussis Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Pertussis Vaccine Value by Countries (2015-2020)
7.2 Europe Pertussis Vaccine Consumption by Type
7.3 Europe Pertussis Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pertussis Vaccine by Countries
8.1.1 Middle East & Africa Pertussis Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pertussis Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Pertussis Vaccine Consumption by Type
8.3 Middle East & Africa Pertussis Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pertussis Vaccine Distributors
10.3 Pertussis Vaccine Customer
11 Global Pertussis Vaccine Market Forecast
11.1 Global Pertussis Vaccine Consumption Forecast (2021-2025)
11.2 Global Pertussis Vaccine Forecast by Regions
11.2.1 Global Pertussis Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Pertussis Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pertussis Vaccine Forecast by Type
11.8 Global Pertussis Vaccine Forecast by Application
12 Key Players Analysis
12.1 Sanofi Pasteur
12.1.1 Company Information
12.1.2 Pertussis Vaccine Product Offered
12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Pertussis Vaccine Product Offered
12.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Wuhan Institute of Biological Products
12.3.1 Company Information
12.3.2 Pertussis Vaccine Product Offered
12.3.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Wuhan Institute of Biological Products Latest Developments
12.4 Walvax Biotechnology
12.4.1 Company Information
12.4.2 Pertussis Vaccine Product Offered
12.4.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Walvax Biotechnology Latest Developments
12.5 Mitsubishi Tanabe Pharma
12.5.1 Company Information
12.5.2 Pertussis Vaccine Product Offered
12.5.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mitsubishi Tanabe Pharma Latest Developments
12.6 Minhai Biotechnology
12.6.1 Company Information
12.6.2 Pertussis Vaccine Product Offered
12.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Minhai Biotechnology Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pertussis Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Whole-cell vaccines
Table 5. Major Players of Acellular vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Pertussis Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Pertussis Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Pertussis Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Pertussis Vaccine Value by Application (2015-2020)
Table 14. Global Pertussis Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Pertussis Vaccine Sale Price by Application (2015-2020)
Table 16. Global Pertussis Vaccine Sales by Company (2017-2019) (K Doses)
Table 17. Global Pertussis Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Pertussis Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Pertussis Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Pertussis Vaccine Sale Price by Company (2017-2019)
Table 21. Global Pertussis Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Pertussis Vaccine Products Offered
Table 23. Pertussis Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Pertussis Vaccine Consumption by Regions 2015-2020 (K Doses)
Table 25. Global Pertussis Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Pertussis Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Pertussis Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Pertussis Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 29. Americas Pertussis Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Pertussis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Pertussis Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Pertussis Vaccine Consumption by Type (2015-2020) (K Doses)
Table 33. Americas Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Pertussis Vaccine Consumption by Application (2015-2020) (K Doses)
Table 35. Americas Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Pertussis Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 37. APAC Pertussis Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Pertussis Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Pertussis Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Pertussis Vaccine Consumption by Type (2015-2020) (K Doses)
Table 41. APAC Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Pertussis Vaccine Consumption by Application (2015-2020) (K Doses)
Table 43. APAC Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Pertussis Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 45. Europe Pertussis Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Pertussis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Pertussis Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Pertussis Vaccine Consumption by Type (2015-2020) (K Doses)
Table 49. Europe Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Pertussis Vaccine Consumption by Application (2015-2020) (K Doses)
Table 51. Europe Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Pertussis Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 53. Middle East & Africa Pertussis Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Pertussis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Pertussis Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Pertussis Vaccine Consumption by Type (2015-2020) (K Doses)
Table 57. Middle East & Africa Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Pertussis Vaccine Consumption by Application (2015-2020) (K Doses)
Table 59. Middle East & Africa Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Pertussis Vaccine Distributors List
Table 61. Pertussis Vaccine Customer List
Table 62. Global Pertussis Vaccine Consumption Forecast by Countries (2021-2025) (K Doses)
Table 63. Global Pertussis Vaccine Consumption Market Forecast by Regions
Table 64. Global Pertussis Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Pertussis Vaccine Value Market Share Forecast by Regions
Table 66. Global Pertussis Vaccine Consumption Forecast by Type (2021-2025) (K Doses)
Table 67. Global Pertussis Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Pertussis Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Pertussis Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Pertussis Vaccine Consumption Forecast by Application (2021-2025) (K Doses)
Table 71. Global Pertussis Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Pertussis Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Pertussis Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. Sanofi Pasteur Product Offered
Table 75. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 76. Sanofi Pasteur Main Business
Table 77. Sanofi Pasteur Latest Developments
Table 78. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Product Offered
Table 80. GSK Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. GSK Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Wuhan Institute of Biological Products Product Offered
Table 85. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 86. Wuhan Institute of Biological Products Main Business
Table 87. Wuhan Institute of Biological Products Latest Developments
Table 88. Wuhan Institute of Biological Products Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Walvax Biotechnology Product Offered
Table 90. Walvax Biotechnology Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 91. Walvax Biotechnology Main Business
Table 92. Walvax Biotechnology Latest Developments
Table 93. Walvax Biotechnology Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Mitsubishi Tanabe Pharma Product Offered
Table 95. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 96. Mitsubishi Tanabe Pharma Main Business
Table 97. Mitsubishi Tanabe Pharma Latest Developments
Table 98. Mitsubishi Tanabe Pharma Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Minhai Biotechnology Product Offered
Table 100. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 101. Minhai Biotechnology Main Business
Table 102. Minhai Biotechnology Latest Developments
Table 103. Minhai Biotechnology Basic Information, Company Total Revenue (in $ million), Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Pertussis Vaccine
Figure 2. Pertussis Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pertussis Vaccine Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global Pertussis Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Whole-cell vaccines
Figure 7. Product Picture of Acellular vaccines
Figure 8. Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Pertussis Vaccine Value Market Share by Type (2015-2020)
Figure 10. Pertussis Vaccine Consumed in Children
Figure 11. Global Pertussis Vaccine Market: Children (2015-2020) (K Doses)
Figure 12. Global Pertussis Vaccine Market: Children (2015-2020) ($ Millions)
Figure 13. Pertussis Vaccine Consumed in Adults
Figure 14. Global Pertussis Vaccine Market: Adults (2015-2020) (K Doses)
Figure 15. Global Pertussis Vaccine Market: Adults (2015-2020) ($ Millions)
Figure 16. Global Pertussis Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global Pertussis Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global Pertussis Vaccine Sales Market Share by Company in 2017
Figure 19. Global Pertussis Vaccine Sales Market Share by Company in 2019
Figure 20. Global Pertussis Vaccine Revenue Market Share by Company in 2017
Figure 21. Global Pertussis Vaccine Revenue Market Share by Company in 2019
Figure 22. Global Pertussis Vaccine Sale Price by Company in 2019
Figure 23. Global Pertussis Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global Pertussis Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas Pertussis Vaccine Consumption 2015-2020 (K Doses)
Figure 26. Americas Pertussis Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC Pertussis Vaccine Consumption 2015-2020 (K Doses)
Figure 28. APAC Pertussis Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe Pertussis Vaccine Consumption 2015-2020 (K Doses)
Figure 30. Europe Pertussis Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Pertussis Vaccine Consumption 2015-2020 (K Doses)
Figure 32. Middle East & Africa Pertussis Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas Pertussis Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas Pertussis Vaccine Value Market Share by Countries in 2019
Figure 35. Americas Pertussis Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas Pertussis Vaccine Consumption Market Share by Application in 2019
Figure 37. United States Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 38. United States Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 40. Canada Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 42. Mexico Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Pertussis Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC Pertussis Vaccine Value Market Share by Regions in 2019
Figure 45. APAC Pertussis Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC Pertussis Vaccine Consumption Market Share by Application in 2019
Figure 47. China Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 48. China Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 50. Japan Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 52. Korea Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 54. Southeast Asia Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 56. India Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 58. Australia Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Pertussis Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe Pertussis Vaccine Value Market Share by Countries in 2019
Figure 61. Europe Pertussis Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe Pertussis Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 64. Germany Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 66. France Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 68. UK Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 70. Italy Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 72. Russia Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Pertussis Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Pertussis Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Pertussis Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Pertussis Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 78. Egypt Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 80. South Africa Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 82. Israel Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 84. Turkey Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Pertussis Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 86. GCC Countries Pertussis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Pertussis Vaccine Consumption Growth Rate Forecast (2021-2025) (K Doses)
Figure 88. Global Pertussis Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 90. Americas Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 92. APAC Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 94. Europe Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 96. Middle East & Africa Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 98. United States Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 100. Canada Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 102. Mexico Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 104. Brazil Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 105. China Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 106. China Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 108. Japan Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 110. Korea Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 112. Southeast Asia Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 113. India Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 114. India Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 116. Australia Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 118. Germany Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 119. France Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 120. France Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 122. UK Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 124. Italy Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 125. Russia Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 126. Russia Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 127. Spain Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 128. Spain Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 129. Egypt Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 130. Egypt Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 131. South Africa Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 132. South Africa Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 133. Israel Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 134. Israel Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 135. Turkey Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 136. Turkey Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Pertussis Vaccine Consumption 2021-2025 (K Doses)
Figure 138. GCC Countries Pertussis Vaccine Value 2021-2025 ($ Millions)
Figure 139. Sanofi Pasteur Pertussis Vaccine Market Share (2018-2020)
Figure 140. GSK Pertussis Vaccine Market Share (2018-2020)
Figure 141. Wuhan Institute of Biological Products Pertussis Vaccine Market Share (2018-2020)
Figure 142. Walvax Biotechnology Pertussis Vaccine Market Share (2018-2020)
Figure 143. Mitsubishi Tanabe Pharma Pertussis Vaccine Market Share (2018-2020)
Figure 144. Minhai Biotechnology Pertussis Vaccine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets